Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: AIDS. 2021 Jan 1;35(1):45–51. doi: 10.1097/QAD.0000000000002729

Table 1:

Association of HIV Specific Characteristics and Elevated Biomarkers.

sCD14
OR (95%CI)
sCD163
OR (95%CI)
I-FABP
OR (95%CI)
sVCAM-1
OR (95%CI)
sICAM-1
OR (95%CI)
Stratified by HIV status and current CD4 count (cells/mm3)
HIV- 1.00 1.00 1.00 1.00 1.00
HIV+, CD4 ≥500 7.87 (4.36 - 12.22) 7.70 (1.56 - 5.38) 2.21 (1.31 - 3.77) 2.34 (1.24 - 3.14) 3.86 (2.25 - 6.63)
HIV+, 200> CD4 <500 8.79 (4.66 - 15.59) 2.39 (1.10 - 5.21) 3.43 (1.95 - 6.02) 1.73 (1.17 - 3.08) 3.54 (1.94 - 6.45)
HIV+, CD4 ≤200 9.32 (3.49 - 22.85) 2.49 (1.11 - 5.88) 4.59 (1.80 - 11.72) 2.36 (1.05 - 6.10) 3.61 (1.33 - 9.74)
Stratified by HIV status and viral load (copies/mL)
HIV- 1.00 1.00 1.00 1.00 1.00
HIV+,VL <50 7.61 (3.06 - 15.95) 2.40 (1.28 - 4.55) 2.71 (1.76 - 4.35) 1.91 (1.21 - 3.02) 3.65 (2.22 - 5.99)
HIV+, VL ≥50 8.61 (4.94 - 14.99) 4.88 (1.71 - 9.97) 3.26 (1.38 - 7.69) 3.97 (1.71 - 9.19) 5.29 (2.20 - 12.67)
Stratified by HIV status and ART duration (years)
HIV- 1.00 1.00 1.00 1.00 1.00
HIV+, ART <4 8.35 (4.77 - 18.33) 3.53 (1.73 - 5.88) 3.74 (2.04 - 6.87) 3.10 (1.71 - 5.62) 4.42 (2.36- 8.28)
HIV+, ART 4-10 7.83 (4.23- 13.65) 2.83 (1.42 - 4.93) 2.91 (1.67- 5.06) 1.05 (0.88 - 2.70) 1.01 (0.78- 3.26)
HIV+, ART >10 7.29 (3.92 - 12.52) 1.81 (1.33 - 4.01) 2.61 (1.48 - 4.59) 1.02 (0.82 - 2.56) 1.08 (0.79- 3.48)

OR, Odds Ratio; CI, confidence interval. ART, antiretroviral therapy; and VL, viral load. Other abbreviations as in Table 1

Model are adjusted for age, dyslipidemia, BMI, hypertension, diabetes, smoking status.